129 results
Page 3 of 7
6-K
EX-99.5
r9ssyp6 g2
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.6
rwjy6dm3h4ph
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.4
umrzg7a
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
ibz0 039fmrrwgvto9xi
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.2
hs5zvtp8fxe0im3lw
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
7cts x2bglx
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
9uen49
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
uqzqcuarau nhp2jnz
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
7kwhtw7 6z35y
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
kst15n
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
zv4mmbwvgbdv5th y9x
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
mwtx91qzrr6o
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
25jt87p7
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
vepqv wdx4kj
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.1
75dr117ef il
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
bnp73m01fbc 2h6
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
ppgx0je
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm